[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$canta Graphic](https://lunarcrush.com/gi/w:26/t:$canta.png) $canta

Cantargia's CAN10 IL1RAP immunology program is acquired by Otsuka Pharmaceutical for $33M upfront and up to $580M in milestones. Redeye will host a live update with Cantargia's CEO to discuss the deal.

### About $canta
Cantargia ($canta) is a biotechnology company.  

### Insights [#](/topic/$canta/insights)
- $canta creators is at X which is XXX% higher than it's daily average.
- $canta mentions is at X which is XXX% higher than it's daily average.
- $canta creators is up XXX% from the previous week.
- $canta mentions is up XXX% from the previous month.
- $canta Creators hit a high of X for the day
- $canta Creators hit an all time of X for the day
- $canta Mentions hit a high of X for the day
- $canta Mentions hit an all time of X for the day
- $canta Engagements hit a high of XXXXX for the day
- $canta Engagements hit an all time of XXXXX for the day

### Engagements: XXX [#](/topic/$canta/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$canta/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$canta/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXXXX +265%  
**1-Year High**: XXXXX on 2025-07-15  
**1-Year Low**: X on 2025-05-09  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$canta/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$canta/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$canta/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: XX +22%  
**1 Month**: XX +240%  
**1-Year High**: X on 2025-07-17  
**1-Year Low**: X on 2025-04-27  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$canta/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$canta/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$canta/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $canta in the last XX hours which is up XX% from X in the previous XX hours
**Daily Average**: X  
**1 Week**: X +200%  
**1 Month**: X +133%  
**1-Year High**: X on 2025-07-17  
**1-Year Low**: X on 2025-04-27  
  
  
### Sentiment: XXX% [#](/topic/$canta/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$canta/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$canta/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XXX%  
**1-Year High**: XXX% on 2025-07-03  
**1-Year Low**: XXX% on 2025-07-03  

**Most Supportive Themes**
- **Acquisition by Otsuka Pharmaceutical:** (75%) Cantargia announces the acquisition of its CAN10 IL1RAP immunology program by Otsuka Pharmaceutical.
- **Redeye Live Update:** (25%) Redeye will have a live update with Cantargia at XXXXX in which we will interview CEO Damian Marron about the deal with Otsuka Pharmaceutical.
  
**Most Critical Themes**
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XX       | XX% | XX      | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XX       | XX% | XX      | XX% | X        | X% |
  


**Top assets mentioned**
In the posts about $canta in the last XX hours

[Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk)
[Lantheus Holdings, Inc (LNTH)](/topic/$lnth)
[Ellipsis (EPS)](/topic/$eps)
[Story (STORY)](/topic/$story)
[TrueChain (TRUE)](/topic/$true)
[Story (STORY)](/topic/story-token)
[BioPassport Token (BIOT)](/topic/$biot)

**Top topics mentioned**
In the posts about $canta in the last XX hours

[$4768t](/topic/$4768t), [$4578t](/topic/$4578t), [abus](/topic/abus), [$ghrs](/topic/$ghrs), [$fna](/topic/$fna), [$phat](/topic/$phat), [$rgnx](/topic/$rgnx), [$siga](/topic/$siga), [$urgn](/topic/$urgn), [$crbp](/topic/$crbp), [$aplt](/topic/$aplt), [$cdmo](/topic/$cdmo), [$oric](/topic/$oric), [$repl](/topic/$repl), [$lxrx](/topic/$lxrx), [$abvx](/topic/$abvx), [$adpt](/topic/$adpt), [$tvtx](/topic/$tvtx), [$cuv](/topic/$cuv), [$abus](/topic/$abus), [$eras](/topic/$eras), [$meso](/topic/$meso), [$avbp](/topic/$avbp), [$stok](/topic/$stok), [$crgx](/topic/$crgx), [$zyme](/topic/$zyme), [$pahc](/topic/$pahc), [$ontx](/topic/$ontx), [$svra](/topic/$svra), [$wve](/topic/$wve), [$cvac](/topic/$cvac), [$nuvb](/topic/$nuvb), [$auph](/topic/$auph), [$ctkb](/topic/$ctkb), [$icpt](/topic/$icpt), [$plrx](/topic/$plrx), [investment](/topic/investment), [$srrk](/topic/$srrk), [$lenz](/topic/$lenz), [coins defi](/topic/coins-defi), [$580m](/topic/$580m), [$33m](/topic/$33m), [acquisition](/topic/acquisition), [$lnth](/topic/$lnth), [eps](/topic/eps), [$eps](/topic/$eps), [$sinchst](/topic/$sinchst), [$secare](/topic/$secare), [$caltx](/topic/$caltx), [$cint](/topic/$cint), [$embrac](/topic/$embrac), [$sinch](/topic/$sinch), [$story](/topic/$story), [$true](/topic/$true), [$hnsa](/topic/$hnsa), [story token](/topic/story-token), [coins bsc](/topic/coins-bsc), [$biot](/topic/$biot)

### Top Social Posts [#](/topic/$canta/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Nadunolimab crushes 2L NSCLC std care91% ORR XXXX mo OS in non-sq post-PD1 vs. 1425% XXX mo. #LungCancer #il1rap #cantargia $canta ##biotech"  
[@cantargia](/creator/x/cantargia) on [X](/post/tweet/1945400160437059837) 2025-07-16 08:28:36 UTC XX followers, XXX engagements


"$CANTA #Cantargia +195% - announces the acquisition of its CAN10 IL1RAP immunology program by Otsuka Pharmaceutical. $33M upfront + up to $580M milestones + earn-out payments from global product sales"  
[@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1945120204935098798) 2025-07-15 13:56:10 UTC 4839 followers, 1706 engagements


"Redeye will have a live update with Cantargia at XXXXX in which we will interview CEO Damian Marron about the deal with Otsuka Pharmaceutical. $CANTA"  
[@Redeye_](/creator/x/Redeye_) on [X](/post/tweet/1945085684395499759) 2025-07-15 11:38:59 UTC 14.5K followers, 1657 engagements


"Live Update: Cantargia Redeye will have a live update with Cantargia at XXXXX in which we will interview CEO Damian Marron about the deal with Otsuka Pharmaceutical. $CANTA"  
[@FrillePelle](/creator/x/FrillePelle) on [X](/post/tweet/1945083695330640216) 2025-07-15 11:31:05 UTC XXX followers, XXX engagements